CLASSYS : Forecast on Business Performance according to Consolidated Financial Statements(Fair Disclosure)
August 09, 2022 at 09:54 pm EDT
Share
Forecast on Business Performance according to Consolidated Financial Statements(Fair Disclosure)
※ The followings are the estimates, not final figures.
1. Details of forecasted Information
Classification(unit : bil. KRW)
2022
Fiscal Year
2023
Fiscal Year
2024
Fiscal Year
Forecast Period
From
2022-01-01
-
-
To
2022-12-31
-
-
Sales Amount
137.5
-
-
Operating Income
-
-
-
Profit from continuing operation before corporate income tax
-
-
-
Net Income
-
-
-
-
-
-
-
2. Basis for Forecast or Estimation
Internal business projections & Industry forecasts
3. Details of Information Released
Information Provider
Classys Inc.
Information Recipients
Individual investors and institutional investors, analysts, etc.
Date & Time of Information Released
August 9, 2022
Title and Place of Event held
-
4. Contact Points
Disclosure Officer (tel.)
Yoonseok Choi Director (1544-3481)
Disclosure Staff (tel.)
Hyunmin Kim Manager (070-5151-2386)
Dept. Name (tel.)
Management Planning Team (1544-3481)
5. Other references concerning investment decisions
'- The above forecast on business performance is on a consolidated basis under K-IFRS.
- The above forecast on business performance is projected based on our business strategies, investment plans, and industry trend.
* Classys provides a sales guidance of KRW 135 to 140 billion
- The above forecasts are forward-looking, and by their nature, involve risks and uncertainties. Thus, actual results may differ from those expressed in this disclosure, depending on factors including macro-economic conditions and business environment.
※Title and date of other disclosure related to this one
-
Attachments
Original Link
Original Document
Permalink
Disclaimer
Classys Inc. published this content on 10 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2022 01:53:05 UTC.
Classys Inc is a Korea-based company principally engaged in the manufacture and sale of electromedical devices. The Company is engaged in the manufacture and sale of hospital medical devices, skin care devices and other products. In addition, the Company is engaged in the manufacture and sale of masks, nourishing creams and other cosmetics. The Company sells its products within domestic market and to overseas markets. The Company was established in 2007 and is located in Gangnam-gu, Seoul, South Korea.